In-Stent Restenosis Post-Approval Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 108 participants.

Also called NCT02542267

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 108 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02542267
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Germany, Italy, Sweden (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02542267. Allocation not applicable; no masking; primary purpose treatment. Start 2015-09 (registry gives no type); primary completion 2019-07 (actual). Results posted on 2020-08-21.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
In-Stent Restenosis Post-Approval Study
Condition
Peripheral Artery Disease
Condition
Vascular Disease
Intervention (Device)
Gore VIABAHN Endoprosthesis
Lead sponsor
W.L.Gore & Associates (class: industry)

Record details

Record id
cardio:ct-nct02542267
Content hash
061a97b4055b6dcd903237ac0c92c7753df2a4525ecb0c21e8983b958af615e8